Scienture Holdings, Inc. (NASDAQ:SCNX) Short Interest Update

Scienture Holdings, Inc. (NASDAQ:SCNX) was the recipient of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 1,022,272 shares, a drop of 36.4% from the August 15th total of 1,607,698 shares. Based on an average trading volume of 400,597 shares, the days-to-cover ratio is presently 2.6 days. Currently, 3.2% of the company’s shares are short sold.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Scienture in a report on Wednesday, June 24th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $1.50.

Hedge Funds Weigh In On Scienture

An institutional investor recently bought a new stake in Scienture stock. Susquehanna International Group LLP acquired a new stake in Scienture Holdings, Inc. (NASDAQ:SCNX) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 235,117 shares of the company’s stock, valued at approximately $82,000. Susquehanna International Group LLP owned about 0.57% of Scienture as of its most recent SEC filing. Hedge funds and other institutional investors own 5.68% of the company’s stock.

Scienture Stock Down 3.0%

Shares of SCNX traded down $0.01 during trading on Thursday, reaching $0.32. The company’s stock had a trading volume of 235,137 shares, compared to its average volume of 2,214,139. The company has a market cap of $13.18 million, a price-to-earnings ratio of -0.15 and a beta of 3.25. The company has a quick ratio of 2.97, a current ratio of 3.04 and a debt-to-equity ratio of 0.15. The company has a fifty day moving average of $0.39 and a two-hundred day moving average of $0.39. Scienture has a twelve month low of $0.24 and a twelve month high of $2.60.

Scienture (NASDAQ:SCNX) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02. The company had revenue of $0.34 million during the quarter, compared to the consensus estimate of $1.96 million.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.